Member Info for alfista

Right. What is the first thing that happens when sales are on the increase? Orders to suppliers are triggered, warehouses increase inventories, shop managers ask for more back up stock to keep their shelves stocked. All the right sort of problems, nothing wrong at all. If demand then catches up with stocks, bank balance improves. Thiss yo-yo effect causes cash in hand to fluctuate, and at the point where it is measured, interim and final, a mill or so either way is meaningless. The provisions made for poor performing store closures have a finite limit, that part of adjustment to the new market conditions will not continue for ever. The good part of the business is demonstrating ability to perform against stiff competition, and perform better than most. Breakeven is within sight, profit and dividend will have the desired effect on this as an investment.

Is that right? Oh, then my forty plus years in retail have been based on wrong assumptions then. I think maybe you should have another read of the trading update, and previous financial reports, where their buying pattern is clearly set out. Some other industries can play the cashflow game and use suppliers credit terms to advantage, but this is not one of them.

Two salient points from the last trading update appear to have gone largely unnoticed. Sales rose strongly in this period, up 9.6% No "Sale" discounting, meaning gross margins have improved. This underlying strength suggest to me that management are doing a good job of positioning the brand to appeal to fashion buyers. Cash at bank went down for the simple reason that higher volume requires more inventory. When the store closure program tails off there is a very strong cash generative business here IMHO

The share being tipped caused a few more buys a while back, but this time looks like mostly a single buyer judging by the regularity and size of buys. Still overlooked by most though

String of 5k buys today giving the Ask a nice leg up. We are a quiet bunch, just a bit more activity here would have benefitted the sp quite a bit I reckon. On the other hand, the stability is really impressive. so we certainly don't need the herd arriving IMHO

Some very decent sized buying here of late. Someone shelled out just shy of £20k in one hit this morning. In times past, that would have shifted the Ask big style, hard to imagine there are that many shares in free float. Puzzling.

Quite a slanted article that one, more journalism than fact as far as I can see. No mention of the paying down of debt over recent years for example. Where I do agree though, is that emphasis on growing existing agencies could and should bring better rewards than acquisitions, since we have seen that acquired companies bring risk with them. We can hope that divis become progressive as a means of attracting more investors, but the growth potential in the sp is obvious to all but that narrow minded scribbler IMHO

Congratulations to the group agencies for an outstanding performance at the awards this year. Such accolades can only serve to strengthen and enhance their images, helping secure further growth opportunities. Multiple win-wins !

Clearly you have a stuck record theme, which makes me doubt your credentials. Blind repetition shows you up in a bad light IMO, you need to produce reasons why you think the business model is not valid, or evidence that the stated targets of the business are not being executed. I have laid out what they have said they want to do with this business, and what has actually happened under the control of the CEO. If you have criticisms of that, then say so, examination of performance is good. As for Provexis, which SM was founder and CEO of in the past, watch that space and comment as you see fit, but there are growing signs that Fruitflow performance will please holders more and more as this year goes on. The development of Fruitflow was the core reason to invest in PXS, so, if the product starts to show its true potential in financial terms, then it could be said that the business model there has been a success. Too early to give facts and figures to back up that opinion, but the anecdotal signs are giving good indications IMHO

Well you keep posting the same thing, and the pursuit of individuals on the web with derogatory comments has become known as trolling, so I guess if the cap fits. However, the facts surrounding Science in Sport, and the changes which have occurred since it was taken over by Provexis, and subsequently floated as a separate AIM listed company, indicate that a growth strategy has been implemented very successfully. The medium term target is to grow the business across domestic and export markets. In past updates the GPM has increased, although I expect that to fall as bulk selling to export markets impacts on margins. Production capacity still has a way to run before extra expenditure would become a factor, marketing spend is impacting on bottom line profits, but in order to grow that is entirely the right place to be investing money. Outright profits may be some time away, but an international brand is being built. The CEO and the rest of the management team seem to me to be doing a good job of executing stated strategy.

New Singapore office good, start up costs may have a short term impact? Wish Poppy and her new team all success in establishing a presence in this dynamic growth area of the world.

Then I wouldn't get any pay would I ? In fact you are quite wrong. Uniquely, I am the one that posted up my buys as they were made, so anyone who felt the need could check the trade going through. Bit inconvenient, and a bit of a playground reponse there. I say Route offers no evidence due to the almost pathalogical hatred of the way markets work. Logical assumption.

You appear to have a misunderstanding of the way AIM listed companies work. The investors are us, or me anyway, as I have seen no evidence that you hold any shares. Your complete mistrust of all things corporate, and your anarchic posting style, suggests to me that you would find the concept of being an investor abhorrent. So, there is no compulsion for directors to buy shares, they are often granted options and share awards by their remuneration committees, and they do at times buy shares , as the directors here did at the demerger and during the recent placing. However, and this is the bit you don't seem to understand, there is NO right of any PI to expect them to buy shares, it is entirely their own choice. That is the way the market works, always was, and, though you don't like it, it would be better for your morbid personality if you reconciled yourself to unchangeable facts..

So let's understand what you are saying. You have no problem with SiS, and the revenue growth and sales territiory expansion, and the increased product offer, and the high profile sports stars endorsing the company, and the online sales department, and the new direct sales department, and the international sales department. That;s good, agree with that, but find it a bit paradoxical that you don't support the CEO who has overseen all of that. Not seeking to change your mind, that would be as pointless as imagining a Route1 post that wasn'y bitterly vindictive. Just find it hard to tie in the two facts, thats all.

You've staked your colours to the mast on that one. The decision of the BoD of Provexis to acquire Science in Sport appears to have been a positive one as far as I can see. They identified a highly regarded fledgling business which had barely advanced past the owbers mum preparing the product in the family kitchen. It was considered to be a candidate for growth by investing in the two P's. Production. A state of the art factory in a low cost area of the country. Promotion. Multiple endorsements from absolute world class athletes, fantastic Olympic success, ibcreased PR, big increases on media presence, web position improved beyond recognition, export drive under way. So tell me, as a business, what wrong steps have been taken by the same team that achieved continual double digit growth for Lucozade? It could be argued that damage was done to Provexis' finances by the decision, but that is now history as Science in Sport is an entirely different entity.

From the results we can see that the growth plan is being executed. Only the financial results will tell us if the GPP has been reduced as is being implied. I doubt that it will have. In a year's time I would expect it to have dipped as they have now begun selling in bulk to export markets, but establishing a strong export section is vital for the future IMHO.

Shocking isn't it. A CEO getting paid, a CEO driving a car, a CEO having a life and making the odd mention of it on social media. Whatever is the world coming to. SiS sales rising quickly, even before international sales rev up. Naah nobody achieved that, just happened.

Nice bit of upward movement today. Are we getting back to tick ups on modest buys again? There surely can not be many free float shares kicking around these days.

Our major shaeholder adds a further million shares, taking their stake past 18%, and here at Silence in Sport there is barely a murmur. No acknowledgement of investment confidence from tutti routey?

Top marks for trying, but what makes you think it has a bean invested in any share? Interested to know where you get your prediction from? Exceptionals yes, the forming and listing of an AIM coimpany will have incurred costs, as will the move of head office. But losses before exceptionals is much harder to identify as far as I can see. The enthusiasm of new institutionals to get involved is a good sign, as is the over budget sales growth and the clear sign that growth will continue due to export sales. So I agree,that the effect of new establishment may impact on sp at the report date, but equally the current year's progress may overtake that effect. Hard to call, but things moving strongly in the right direction IMHO. Can you imagine what the latest moves would have done to moods had this still been part of the old set up? It already seems an age ago.